Inhaled NO for the Prevention of Chronic Lung Disease
Phase of Trial: Phase III
Latest Information Update: 30 Jul 2015
At a glance
- Drugs Nitric oxide (Primary)
- Indications Lung disorders; Respiratory insufficiency
- Focus Adverse reactions
- 07 May 2013 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health; NCT00006401).
- 05 Nov 2010 New trial record.